Victoria Bainer, n/a

Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• Paper 46 - GENOMIC FEATURES AND CIRCULATING TUMOR DNA IN PATIENTS WITH INTERMIDIATE RISK RHABDOMYOSARCOMA TREATED ON ARST1431 AN INTERIM REPORT FROM THE CHILDRENS ONCOLOGY GROUP

  Friday, November 3, 2023
  2:30 PM – 4:00 PM  

• Paper 65 - PRE-TREATMENT CTDNA BURDEN AND GENOMIC FEATURES ARE PROGNOSTIC AMONG PATIENTS WITH METASTATIC EWING SARCOMA TREATED ON AEWS1221: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (COG)

  Saturday, November 4, 2023
  10:00 AM – 11:00 AM